Page 1 of Clinical Trials for Deficiency Disease, 5906 Total Matches
- 1Active, not recruitingLast Updated: December 16, 2011Condition(s): Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
- 2CompletedLast Updated: September 3, 2009Condition(s): Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
- 3CompletedLast Updated: July 31, 2009Condition(s): Gaucher Disease Type I; Cerebroside Lipidosis Syndrome; Clucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
- 4RecruitingLast Updated: December 8, 2011Condition(s): Gaucher Disease; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease
- 5RecruitingLast Updated: January 25, 2012Condition(s): Urea Cycle Disorders; Carbamoylphosphate Synthetase I Deficiency Disease; Ornithine Transcarbamylase Deficiency Disease; Citrullinemia
- 6CompletedLast Updated: March 12, 2012Condition(s): Immunologic Deficiency Syndromes
- 7Not yet recruitingLast Updated: May 14, 2012Condition(s): Propionic Acidemia (PA); Methylmalonic Acidemia (MMA); Late-onset CPS1 Deficiency (CPSD); Late-onset Ornithine Transcarbamylase Deficiency (OTCD)
- 8CompletedLast Updated: June 29, 2009Condition(s): T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
- 9SuspendedLast Updated: February 6, 2009Condition(s): Canavan Disease; Infantile; Deficiency Disease; Aspartoacylase; Leukodystrophy, Spongiform
- 10CompletedLast Updated: March 3, 2008Condition(s): Healthy; Deficiency Disease
- 11Active, not recruitingLast Updated: June 23, 2005Condition(s): Ornithine Transcarbamylase Deficiency Disease
- 12TerminatedPhase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase DeficiencyLast Updated: June 23, 2005Condition(s): Ornithine Transcarbamylase Deficiency Disease
- 13CompletedLast Updated: July 7, 2009Condition(s): Pompe Disease (Late-Onset); Glycogen Storage Disease Type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2
- 14CompletedLast Updated: July 7, 2009Condition(s): Pompe Disease (Late-Onset); Glycogen Storage Disease Type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2
- 15CompletedLast Updated: June 24, 2010Condition(s): Pompe Disease (Late-onset); Glycogen Storage Disease Type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2
- 16CompletedLast Updated: March 14, 2011Condition(s): Glycogen Storage Disease Type II; Pompe Disease; Acid Maltase Deficiency Disease; Glycogenosis 2
- 17CompletedLast Updated: July 6, 2009Condition(s): Glycogen Storage Disease Type II; Pompe Disease; Acid Maltase Deficiency Disease; Glycogenosis 2
- 18CompletedLast Updated: August 4, 2009Condition(s): Pompe Disease; Glycogen Storage Disease Type II; Acid Maltase Deficiency Disease; Glycogenosis 2
- 19RecruitingLast Updated: May 4, 2012Condition(s): Pompe Disease; Glycogen Storage Disease Type II (GSD-II); Acid Maltase Deficiency Disease
- 20Approved for marketingLast Updated: October 25, 2010Condition(s): Glycogen Storage Disease Type II (GSD-II); Pompe Disease (Late-onset); Acid Maltase Deficiency Disease; Glycogenosis 2
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Deficiency+Disease
